Your browser doesn't support javascript.
loading
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-ß1b (MIRACLE trial): study protocol for a randomized controlled trial.
Arabi, Yaseen M; Alothman, Adel; Balkhy, Hanan H; Al-Dawood, Abdulaziz; AlJohani, Sameera; Al Harbi, Shmeylan; Kojan, Suleiman; Al Jeraisy, Majed; Deeb, Ahmad M; Assiri, Abdullah M; Al-Hameed, Fahad; AlSaedi, Asim; Mandourah, Yasser; Almekhlafi, Ghaleb A; Sherbeeni, Nisreen Murad; Elzein, Fatehi Elnour; Memon, Javed; Taha, Yusri; Almotairi, Abdullah; Maghrabi, Khalid A; Qushmaq, Ismael; Al Bshabshe, Ali; Kharaba, Ayman; Shalhoub, Sarah; Jose, Jesna; Fowler, Robert A; Hayden, Frederick G; Hussein, Mohamed A.
Afiliación
  • Arabi YM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. arabi@ngha.med.sa.
  • Alothman A; Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia. arabi@ngha.med.sa.
  • Balkhy HH; International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ, UK. arabi@ngha.med.sa.
  • Al-Dawood A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • AlJohani S; Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Al Harbi S; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Kojan S; Department of Infection Prevention and Control, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Al Jeraisy M; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Deeb AM; Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Assiri AM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Al-Hameed F; Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • AlSaedi A; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Mandourah Y; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Almekhlafi GA; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Sherbeeni NM; Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Elzein FE; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Memon J; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Taha Y; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Almotairi A; Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Maghrabi KA; Infection Prevention and Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Qushmaq I; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
  • Al Bshabshe A; Intensive Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Kharaba A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
  • Shalhoub S; Department of Infection Prevention and Control, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Jose J; Department of Intensive Care Services, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Fowler RA; Department of Intensive Care Services, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Hayden FG; Infectious Diseases Division, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Hussein MA; Infectious Diseases Division, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Trials ; 19(1): 81, 2018 Jan 30.
Article en En | MEDLINE | ID: mdl-29382391
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Infecciones por Coronavirus / Ritonavir / Lopinavir / Coronavirus del Síndrome Respiratorio de Oriente Medio / Interferon beta-1b Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Qualitative_research Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Infecciones por Coronavirus / Ritonavir / Lopinavir / Coronavirus del Síndrome Respiratorio de Oriente Medio / Interferon beta-1b Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Qualitative_research Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Arabia Saudita